Water Load Test Value for Hyponatremia
NCT04256499 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2020-02-05
Summary
Acute water load test has been using to diagnose renal ability to excrete water for decades. Latest recommendations for the diagnosis of hyponatremia do not recommend performing such a test. The investigators aim at, retrospectively, study the value of acute water load test in patients suffering from a syndrome of inappropriate antidiuresis.
Conditions
- SIAD - Syndrome of Inappropriate Antidiuresis
- Hyponatremia
Interventions
- PROCEDURE
-
Acute water load test
The acute water load test consists in administering orally 20 mL/kg (of body weight) of water (ingested in less than 30 min) and then follow (during 4 to 6 hours) blood and urine parameters.
Sponsors & Collaborators
-
European Georges Pompidou Hospital
lead OTHER
Principal Investigators
-
Jean-Philippe Bertocchio, MD, PhD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-01-01
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- France
Study Locations
More Related Trials
-
A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
NCT00728091 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00264914 ·Status: COMPLETED ·Phase: PHASE3
-
Saline Infusion Test in Hyponatremia
NCT06498856 ·Status: NOT_YET_RECRUITING
-
Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
NCT05411991 ·Status: COMPLETED ·Phase: PHASE4
-
Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia
NCT03557957 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH
NCT03048747 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00435591 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00264927 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
NCT03202667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism
NCT06236698 ·Status: COMPLETED
-
Effect of Protein Supplementation on Plasma Sodium Levels and Urinary Urea Excretion in Patients With SIAD
NCT04987385 ·Status: COMPLETED ·Phase: NA
-
Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome
NCT05055856 ·Status: COMPLETED ·Phase: NA
-
Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients.
NCT05408481 ·Status: UNKNOWN
-
Effect of Acetazolamide on Diuresis and Natriuresis in Patients With Acute Heart Failure (SANDI STUDY)
NCT06285760 ·Status: RECRUITING
-
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
NCT02183792 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnosing Natriuretic Peptide Deficiency
NCT03035929 ·Status: COMPLETED ·Phase: PHASE1
-
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00380575 ·Status: COMPLETED ·Phase: PHASE3
-
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
NCT06750172 ·Status: RECRUITING
-
Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients
NCT01456533 ·Status: COMPLETED
-
Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia
NCT04447911 ·Status: RECRUITING ·Phase: PHASE4
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA
-
An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00379847 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study
NCT02874807 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Acute Salt Handling in Orthostatic Intolerance
NCT00581633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia
NCT00660959 ·Status: COMPLETED ·Phase: PHASE3